Registry collects samples and data from young people with rare brain tumors
Collects tissue samples and health records from young people with rare brain tumors.
Key facts
- Who runs it
- Children's National Research Institute
- Where
- São Paulo, BrazilSee the siteAlso in 3 other countries, 12 sites
- Trial code
- Registry title
- International Rare Brain Tumor Registry
- Status
- Recruiting
- People taking part
- 5,800 people, planned
- Started
- 1 Jan 2023
- Expected to end
- Dec 2033
- Type of study
- Observational, 5 groups
- Record updated
- 7 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for children, teenagers and young adults with a known or suspected rare brain tumor. It collects tissue samples and health information.
- Age
- Up to 45 Years. The exclusion list says people older than 46 years at diagnosis cannot join.
- Sex
- All sexes can join.
- Disease stage
- A known or suspected rare brain tumor: CNS sarcoma, BCOR-altered brain tumor, astroblastoma/NM-1 altered brain tumor, or a brain tumor that is unclear or cannot be classified.
Main reasons for not taking part
- The patient has a primary tumor outside the central nervous system (extra-CNS).
- The patient is older than 46 years of age at diagnosis.
- The patient or family is not willing to take part or does not sign informed consent.
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients with a known or suspected CNS Sarcoma
- Patients with a known or suspected BCOR-altered brain tumor
- Patients with a known or suspected Astroblastoma/NM-1 altered brain tumor
- Patients with known or suspected histologically ambiguous/unclassifiable brain tumor
- Patients with a known or suspected rare brain tumor
- Signed informed consent by patient/ parent or guardian (assent where applicable) to participate in the study
Who cannot take part
- The patient is older than 46 years of age at diagnosis
- The patient has an extra-CNS primary tumor
- The patient or family is not willing to participate or does not sign informed consent
Where in Brazil
Also in 3 other countries, 12 sites
- TUCCA - Santa MarcelinaSão Paulo, BrazilContact: Sidnei Epelman, MDTaking people
About the trial
What the trial wants to find out
The objective of the International Rare Brain Tumor Registry (IRBTR) is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children, adolescents, and young adult patients diagnosed with rare brain tumors.
The 5 groups in the trial
- CNS Sarcoma
Patients diagnosed with Central nervous system (CNS) sarcomas
- BCOR-altered
Patients diagnosed with tumors characterized by alterations in the BCOR gene.
- Astroblastoma/MN-1- altered
Patients diagnosed with Astroblastomas/MN-1 alterations
- Unclassifiable tumors
Patients diagnosed with histologically ambiguous tumors or tumors that fail to classify with the current diagnostic methods.
- Other Rare Brain tumors
Patients diagnosed with other rare brain tumors that do not meet the criteria for cohorts 1-4.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- International Rare Brain Tumor Registry
- Plain-language title
- Registry collects samples and data from young people with rare brain tumorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 7 August 2026